ACTU vs GILD: Which Stock is Better?
Side-by-side comparison of Actuate Therapeutics Inc and Gilead Sciences Inc in 2026
ACTU
Actuate Therapeutics Inc
$5.56
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ACTU | GILD | Winner |
|---|---|---|---|
| Market Cap | $136.67M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.7% | GILD |
Analyze ACTU
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACTU or GILD a better investment?
Comparing ACTU and GILD: Actuate Therapeutics Inc has a market cap of $136.67M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACTU and GILD?
ACTU (Actuate Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACTU or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACTU or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for ACTU.
Which company is more profitable: ACTU or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for ACTU.
Which is the larger company: ACTU or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $136.67M for ACTU.
Should I buy ACTU or GILD in 2026?
Both ACTU and GILD have investment merit. ACTU trades at $5.56 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACTU and GILD stock?
Key differences: Market Cap ($136.67M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).